EHS
EHS

New patent expiration for Acrotech drug FOLOTYN – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for Acrotech drug FOLOTYN


Annual Drug Patent Expirations for FOLOTYN

Folotyn is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for FOLOTYN.

This drug has thirty-nine patent family members in twenty-three countries.

The generic ingredient in FOLOTYN is pralatrexate. One supplier is listed for this compound. Additional details are available on the pralatrexate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Acrotech drug FOLOTYN



Source link

EHS
Back to top button